Literature DB >> 21997980

Genetics and imaging of hepatocellular adenomas: 2011 update.

Venkata S Katabathina1, Christine O Menias, Alampady K P Shanbhogue, Jaishree Jagirdar, Raj Mohan Paspulati, Srinivasa R Prasad.   

Abstract

Hepatocellular adenomas are benign liver neoplasms with specific but varied histopathologic findings and tumor biology. The results from recent studies of the pathologic and genetic basis of hepatocellular adenomas provide important insights into the pathogenesis and molecular changes, as well as the putative oncologic pathways used by diverse adenoma subtypes. On the basis of the genetic and pathologic features, hepatocellular adenomas are categorized into three distinct subtypes: (a) inflammatory hepatocellular adenomas, (b) hepatocyte nuclear factor 1 α-mutated hepatocellular adenomas, and (c) β-catenin-mutated hepatocellular adenomas. Different subtypes show variable clinical behavior, imaging findings, and natural history, and thus the options for treatment and surveillance may vary. Cross-sectional imaging plays an important role in the diagnosis, subtype characterization, identification of complications, and surveillance of hepatocellular adenomas. New schemas for genotype-phenotype classification of hepatic adenomas, as well as management triage of patients with specific subtypes of adenomas, are being proposed in an attempt to improve clinical outcomes. ©RSNA, 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997980     DOI: 10.1148/rg.316115527

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  43 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

Review 2.  Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances.

Authors:  A E Obaro; S M Ryan
Journal:  Ultrasound       Date:  2015-03-12

3.  Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit.

Authors:  Nicola de'Angelis; Riccardo Memeo; Julien Calderaro; Emanuele Felli; Chady Salloum; Philippe Compagnon; Alain Luciani; Alexis Laurent; Daniel Cherqui; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2014-05-23       Impact factor: 3.647

Review 4.  Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.

Authors:  Marco Di Pietropaolo; Chiara Briani; Emanuela Pilozzi; Francesco Carbonetti; Vincenzo David; Elsa Iannicelli
Journal:  J Gastrointest Cancer       Date:  2015-12

Review 5.  Magnetic Resonance Imaging of Hepatic Adenoma Subtypes.

Authors:  Vincenzo K Wong; Alice W Fung; Khaled M Elsayes
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 6.  Hepatocyte-specific contrast media: not so simple.

Authors:  Andrew T Trout; Alexander J Towbin; Ethan A Smith; Anita Gupta; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 7.  Magnetic resonance imaging features of common focal liver lesions in children.

Authors:  Prakash M Masand
Journal:  Pediatr Radiol       Date:  2018-08-04

8.  Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.

Authors:  N Shao; A Pandey; M A Ghasabeh; P Khoshpouri; P Pandey; F N Varzaneh; M Zarghampour; D Fouladi; T M Pawlik; R A Anders; I R Kamel
Journal:  Clin Radiol       Date:  2018-07-18       Impact factor: 2.350

9.  Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Osamu Matsui; Satoshi Saitoh; Yoshito Tomimaru; Takeshi Fujii; Toshifumi Gabata
Journal:  Br J Radiol       Date:  2016-05-20       Impact factor: 3.039

10.  Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance.

Authors:  Kumi Ozaki; Kenichi Harada; Toru Yamamoto; Hiroyuki Aoyagi; Yasuharu Kaizaki; Jun Yoshikawa
Journal:  Clin J Gastroenterol       Date:  2017-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.